Case Studies and Project Ideas: Pharmacokinetics - One Compartment


Medicine and the Biosciences Main Page

Other Case Studies and Project Ideas

Drug and Metabolite Absorption and Disposition

Source:

Model design by Dr. Ronald Sawchuck, University of Minnesota. Used by permission. Narrative and case study design by Robert R. Gotwals, Jr.

Goal:

To learn about basic pharmacokinetics through the building and use of a one-compartment model for drug and metabolite first-order absorption and disposition.

Key concepts and terminology:

  • volume of distribution
  • clearance
  • distribution
  • elimination
  • excretion
  • metabolism
  • half-life

    Background Reading:

    The simplest type of model used in the study of pharmacokinetics is the one-compartment model. In this model, we are concerned only with the introduction of a drug into the compartment, followed by its transformation/metabolism and subsequent excretion. Most one-compartment models are closed systems; that is, we must account for all the mass of the drug during the entire simulation. If we dose 80 mg, for example, the entire 80 mg must be accountable during the entire time period of the simulation.

    In looking at a one compartment model, we employ a mass balance approach to the problem. Mass balance is the term used to indicate that we are interested in conserving the mass of the substance, i.e., accounting for all the mass at all times. For a one compartment model, the mass balance equation is as follows:

    Dose = Amount of drug at absorption site + amount of drug in body + amount of drug excreted + amount of metabolite in body + amount of metabolite excreted

    At its most simplistic level, the model can be represented by the graphic:

    Figure 1.

    Another graphic to illustrate this model is as follows:

    Figure 2.

    In this mass balance model, the rates of change -- the flow of the drug through the model -- must be equal to zero according to the following equation:

    Rate of change of drug in body = rate of absorption - rate of elimination

    In any study of pharmacokinetics -- the quantitation of the time course of a drug and its metabolites in the body -- these two components of the mass balance system are typically employed. More complex models are often variations on this theme.

    In addition to the concepts of absorption, elimination, and metabolism, several other parameters play an important role in most pharmacokinetic models. As shown graphically below, the value of the volume of distribution is key. The volume of distribution, calculated here by dividing the dosage by the concentration in the body at the start of the simulation, is defined several ways. Generally, it is defined as the apparent volume into which a drug distributes in the body at equilibrium. Volume of distribution is typically measured in liters (L). Volume of distribution is a direct measure of the extent of distribution, although it rarely corresponds to a real volume. The values for volume of distribution for individual drugs can often be found in the literature. Digoxin, for example, has a volume of distribution of around 500 liters for a normal 70 kg adult.

    Another important concept is that of clearance. Clearance is probably the most useful parameter for the evaluation of an elimination mechanism. Defined, clearance is a proportionality factor relating rate of drug elimination to the plasma/drug concentration. In the graphic below, the clearance is calculated by the rate of clearance times the volume of distribution. The unit for clearance is volume per unit time. For example, if the clearance value is 1 L/hr, then at a concentration of 1 mg/L, the rate of drug elimination is 1 mg/hr. There are a number of ways of estimating clearance -- for this case study, values of clearance will be provided. You might choose to vary these values to investigate their effect on the compartment!

    Both volume of distribution and clearance can be related to each other through the term of half-life. Half-life is that period of time when one-half of the substance has been removed through some mechanism. Mathematically, pharmacokinetic half-life can be defined as:

    It should be noted that a half-life reflects rather than controls the volume of distribution and the clearance, both of which are independent variables.

    Figure 3.

    Building the model:

    The goal of this model is to evaluate a variety of basic parameters, most explicitly the differences between concentrations of a drug over time following intravenous versus oral administration. The model can also be used to investigate different values of clearance and volume of distribution.

    In this model, following the graphic in Figure 2, we are interested in the concentrations of drug in one-compartment, but at five different levels:

    1. initial concentration at the absorption site, Ainitial
    2. concentration of drug in the body, A
    3. concentration of the excreted drug, Aexcreted
    4. concentration of metabolite in the body, M
    5. concentration of eliminated or excreted metabolite, Mexcreted

    Each of the arrows in the graphic suggest the flow of mass from one area to the next. The arrows represent the rates of mass transfer between sections of the model.

    The algorithm for this particular model is outlined below. Using these algorithms and these initial values, your task is to build this model and then use it to investigate a number of scenarios, described in the section below.

    Initial values: Initial A = 0 mg/L if the dosing route is oral, 200 mg/L if the dosing route is IV (note: you should consider using the IF...THEN....ELSE built-in functions to include this feature)

    Initial Ainitial = 200 mg/L if the dosing route is oral, 0 mg/L if the dosing route is IV

    Inital M = 0 mg/L

    Initial Mexcreted = 0 mg/L

    Excreted clearance (CLe): 2.5 L/hr

    Metabolized clearance (CLm): 3.5 L/hr

    Excreted metabolite clearance (CLme): 12.8 L/hr

    ka = 0.5

    Volume of distribution (Vd) = 32 L

    Volume of distribution of the metabolite (Vm) = 24 L

    Simulation time: 48 hours in 15 minute intervals (dt = 0.25 hour)

    In your model, you should also calculate the log (base 10) of the concentration of the drug in the plasma and the log of the concentration of the metabolite.

    Once your model is completed, build a graph plotting all of the stocks (Ai, A, M, Ae, and Me). You should also plot logCp and logCm on the same graph as a function of time.

    Algorithm Set for the Model:

    Using the Model:

    Once you have completed your model, you should try a number of scenarios. What is the difference in the amount of drug in the various compartments between oral and IV dosing? What is the effect of changing various clearances for the model? What is the effect of changing the volumes of distribution?

    References:

    Rowland, M., and Tozer, T. Clinical Pharmacokinetics: Concepts and Applications, Third Edition. Williams and Wilkins, Media, PA, 1995. Shargel, L., and Yu, A. Applied Biopharmaceutics and Pharmacokinetics, Third Edition. Appleton and Lange, East Norwalk, CT, 1993.
    Copyright © 1996 Ronald J. Sawchuk, Ph.D. for the model design. Used by permission.
    Copyright © 1996 Robert R. Gotwals, Jr. for the narrative case study.

    Developed by
    Graphic of Shodor LogoThe Shodor Education Foundation, Inc.
    Copyright © 2000-2003
    Questions or comments about this page should be directed to biomed@shodor.org